FDA panel overly cautious about genetic screening

Wednesday - March 9, 2011 By

An FDA advisory panel this week recommended that physicians oversee the ordering and interpretation of all genetic screeing examinations.  Let’s hope that the FDA rejects the recommendation of the panel – the panel should be directed to redo its homework and focus on the question of reliability and quality, not access. FDA policy should be [...]

Filed Under: Miscellaneous